First two GMP doses of rese-cel manufactured on the Cell Shuttle(TM) met all release specifications, were delivered on time, and have been infused into patients within Cabaletta Bio's RESET(TM) ...
Collaboration with Stanford Medicine establishes a platform manufacturing process and analytics designed to support gene-edited hematopoietic stem cell therapies for HIV and more than 19 rare diseases ...
As the industry pivots towards closed-system, automated manufacturing, the focus has shifted from mere feasibility to sustainable, high-volume production. The ABEA 2026 trophy and certificate of ...
CytoNiche’s 3D FloTrix™ platform won the Emerging Bioprocessing Supplier – Downstream award at ABEA 2026, recognising scalable 3D cell therapy manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results